Skip to main content

Advertisement

Log in

Prevalence and significance of human parvovirus variants in skin from primary cutaneous T cell lymphomas, inflammatory dermatoses and healthy subjects

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Primary cutaneous T cell lymphomas (CTCL) represent a heterogeneous group of T lymphomas. Virus involvement in CTCL pathogenesis has been extensively investigated, but no data are available as to a causative role of parvovirus B19. The prevalence of parvovirus variants (B19, LaL1/K71, V9) was investigated by using two nested PCRs and a genotype-2 semiquantitative PCR (Q-PCR). Parvovirus DNA was detected in similar percentage in healthy skin controls (40%; n = 42), inflammatory dermatoses (ID) (41%; n = 80) and CTCL (34%; n = 76). Among variants, genotype-2 was more prevalent in ID (26%) and CTCL (22%) than in normal skin (14%; p < 0.05). genotype-3 was never found in normal skin and was rare in ID. The only four pathological skin samples with a quantifiable genome copies/μg DNA values in Q-PCR were ID. In conclusion, despite the skin represent a reservoir for genotype-1, parvovirus infection is not involved in the etiopathogenesis of CTCL.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Explore related subjects

Discover the latest articles and news from researchers in related subjects, suggested using machine learning.

References

  1. Baskan EB, Yilmaz E, Saricaoglu H et al (2007) Detection of parvovirus B19 DNA in the lesional skin of patients with Behçet’s disease. Clin Exp Dermatol 32:186–190. doi:10.1111/j.1365-2230.2006.02330.x

    Article  PubMed  CAS  Google Scholar 

  2. Bergallo M, Costa C, Sidoti F et al (2008) Variants of parvovirus B19: bioinformatical evaluation of nested PCR assays and genotypes detection. Intervirol 51:75–80. doi:10.1159/000127429

    Article  CAS  Google Scholar 

  3. Bernengo MG, Novelli M, Quaglino P et al (2001) The relevance of the CD4 + CD26—subset in the identification of circulating Sezary cells. Br J Dermatol 144:124–135. doi:10.1046/j.1365-2133.2001.04014.x

    Article  Google Scholar 

  4. Brown KE, Young NS (1997) Parvovirus B19 in human disease. Annu Rev Med 48:59–67. doi:10.1146/annurev.med.48.1.59

    Article  PubMed  CAS  Google Scholar 

  5. Chevrel G, Calyet A, Belin V et al (2000) Dermatomyositis associated with the presence of parvovirus B19 DNA in muscle. Rheumatology (Oxford) 39:1037–1039. doi:10.1093/rheumatology/39.9.1037

    Article  CAS  Google Scholar 

  6. Crowson AN, Magro CN, Dawood MR (2000) A causal role for parvovirus B19 infection in adult dermatomyositis and other autoimmune syndromes. J Cutan Pathol 27:505–515. doi:10.1034/j.1600-0560.2000.027010505.x

    Article  PubMed  CAS  Google Scholar 

  7. Drago F, Semino M, Rampini P et al (1999) Parvovirus B19 infection associated with acute hepatitis and a purpuric exanthem. Br J Dermatol 141:160–161. doi:10.1046/j.1365-2133.1999.02943.x

    Article  PubMed  CAS  Google Scholar 

  8. Ekman A, Hokynar K, Kakkola L et al (2007) Biological and immunological relations among Human Parvovirus B19 genotypes 1 to 3. J Virol 81:6927–6935. doi:10.1128/JVI.02713-06

    Article  PubMed  CAS  Google Scholar 

  9. Ferri C, Azzi A, Magro CM (2005) Parvovirus B19 and systemic sclerosis. Br J Dermatol 152:819–820. doi:10.1111/j.1365-2133.2005.06515.x

    Article  PubMed  CAS  Google Scholar 

  10. Florea AV, Ionescu DN, Melhem MF (2007) Parvovirus B19 infection in the immunocompromised host. Arch Pathol Lab Med 131:799–804

    PubMed  Google Scholar 

  11. Heegaard ED, Panum Jensen I, Christensen J (2001) Novel PCR assay for differential detection and screening of erythrovirus B19 and erythrovirus V9. J Med Virol 65:362–367. doi:10.1002/jmv.2042

    Article  PubMed  CAS  Google Scholar 

  12. Heegaard ED, Brown KE (2002) Human parvovirus B19. Clin Microbiol Rev 15:485–505. doi:10.1128/CMR.15.3.485-505.2002

    Article  PubMed  Google Scholar 

  13. Hokynar K, Soderlund-Venermo M, Pesonen M et al (2002) A new parvovirus genotype-persistent in human skin. Virology 302:224–228. doi:10.1006/viro.2002.1673

    Article  PubMed  CAS  Google Scholar 

  14. Katta R (2002) Parvovirus B19: a review. Dermatol Clin 20:333–342. doi:10.1016/S0733-8635(01)00013-4

    Article  PubMed  Google Scholar 

  15. Kerr S, O’keeffe G, Kilty C et al (1999) Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG. J Med Virol 57:179–185. doi:10.1002/(SICI)1096-9071(199902)57:2<179::AID-JMV16>3.0.CO;2-T

    Article  PubMed  CAS  Google Scholar 

  16. Labarthe MP, Salomon D, Saurat JH (1996) Ulcération linguales, parapsoriasis en gouttes et primo-infection a parvovirus B19. Ann Dermatol Venereol 123:735–738

    PubMed  CAS  Google Scholar 

  17. Magro CM, Dawood MR, Crowson AN (2000) The cutaneous manifestations of human parvovirus B19 infection. Hum Pathol 31:488–497. doi:10.1053/hp.2000.6714

    Article  PubMed  CAS  Google Scholar 

  18. Nagore E, Ledesda E, Collado C et al (2000) Detection of Epstein–Barr virus and human herpesvirus 7 and 8 genomes in primary cutaneous T and B-cell lymphomas. Br J Dermatol 14:320–323. doi:10.1046/j.1365-2133.2000.03657.x

    Article  Google Scholar 

  19. Nguyen QT, Sifer C, Schneider V et al (1999) Novel human erythrovirus associated with transient aplastic anemia. J Clin Microbiol 37:2483–2487

    PubMed  CAS  Google Scholar 

  20. Nguyen QT, Wong S, Heegaard ED et al (2002) Identification and characterization of a second novel human erythrovirus variant, A6. Virology 301:374–380. doi:10.1006/viro.2002.1585

    Article  PubMed  CAS  Google Scholar 

  21. Norja P, Hokynar K, Aaltonen LM et al (2006) Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci USA 103:7450–7474. doi:10.1073/pnas.0602259103

    Article  PubMed  CAS  Google Scholar 

  22. Novelli M, Merlino C, Ponti R et al. (2009) Epstein-Barr Virus in cutaneous T-Cell Lymphomas: evaluation of the viral presence and significance in skin and peripheral blood. J Invest Dermatol. doi:10.1038/jid.2008.396

  23. Ofuji S, Yamamoto O (2007) Acute generalized exanthematous pustulosis associated with a human parvovirus B19 infection. J Dermatol 34:121–123. doi:10.1111/j.1346-8138.2006.00230.x

    Article  PubMed  Google Scholar 

  24. Olsen E, Vonderheid E, Pimpinelli N et al (2007) Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 110:1713–1722. doi:10.1182/blood-2007-03-055749

    Article  PubMed  CAS  Google Scholar 

  25. Ohtsuka T, Yamazaki S (2005) Altered prevalence of human parvovirus B19 component genes in systemic sclerosis skin tissue. Br J Dermatol 152:1078–1080. doi:10.1111/j.1365-2133.2005.06567.x

    Article  PubMed  CAS  Google Scholar 

  26. Parsyan A, Kerr S, Owusu-Ofori S (2006) Reactivity of genotype-specific recombinant proteins of human erythrovirus B19 with plasmas from areas where genotype 1 or 3 is endemic. J Clin Microbiol 44:1367–1375. doi:10.1128/JCM.44.4.1367-1375.2006

    Article  PubMed  CAS  Google Scholar 

  27. Ponti R, Quaglino P, Novelli M et al (2005) T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings. Br J Dermatol 153:565–573. doi:10.1111/j.1365-2133.2005.06649.x

    Article  PubMed  CAS  Google Scholar 

  28. Ponti R, Fierro MT, Quaglino P et al (2008) TCRgamma-chain gene rearrangement by PCR-based GeneScan: diagnostic accuracy improvement and clonal heterogeneity analysis in multiple cutaneous T-cell lymphoma samples. J Invest Dermatol 128:1030–1038. doi:10.1038/sj.jid.5701109

    Article  PubMed  CAS  Google Scholar 

  29. Ponti R, Bergallo M, Costa C et al (2008) Human Herpesvirus 7 detection by real time quantitative PCR in primary cutaneous T cell lymphomas and healthy subjects: lack of a pathogenic role. Br J Dermatol 159:1131–1137. doi:10.1111/j.1365-2133.2008.08575.x

    Article  PubMed  CAS  Google Scholar 

  30. Reid DM, Reid TMS, Brown T et al (1985) Human parvovirus associated arthritis: a clinical and laboratory description. Lancet 1:422–425. doi:10.1016/S0140-6736(85)91146-8

    Article  PubMed  CAS  Google Scholar 

  31. Schwarz TF, Wiersbitzky S, Pambor M (1994) Case report: detection of parvovirus B19 in a skin biopsy of a patient with erythema infectiosum. J Med Virol 43(2):171–174. doi:10.1002/jmv.1890430214

    Article  PubMed  CAS  Google Scholar 

  32. Servant A, Laperche S, Lallemand F et al (2002) Genetic diversity within human erythroviruses: identification of three genotypes. J Virol 76:9124–9134. doi:10.1128/JVI.76.18.9124-9134.2002

    Article  PubMed  CAS  Google Scholar 

  33. Smith PT, Landry ML, Carey H et al (1998) Papular-purpuric gloves and socks syndrome associated with acute parvovirus B19 infection: case report and review. Clin Infect Dis 27:164–168. doi:10.1086/514629

    Article  PubMed  CAS  Google Scholar 

  34. Soderlund-Venermo M, Hokynar K, Nieminen J et al (2002) Persistence of human parvovirus B19 in human tissues. Pathol Biol 50:307–316. doi:10.1016/S0369-8114(02)00307-3

    Article  PubMed  CAS  Google Scholar 

  35. Tomasini D, Tomasini CF, Cerri A et al (2004) Pityriasis lichenoides: a cytotoxic T-cell-mediated skin disorder. Evidence of human parvovirus B19 DNA in nine cases. J Cutan Pathol 31:531–538. doi:10.1111/j.0303-6987.2004.00186.x

    Article  PubMed  Google Scholar 

  36. Vonderheid EC, Bernengo MG (2003) The Sézary syndrome: hematologic criteria. Hematol Oncol Clin North Am 17:1367–1389. doi:10.1016/S0889-8588(03)00120-5

    Article  PubMed  Google Scholar 

  37. Vuorinen T, Lammintausta K, Kotilainen P et al (2002) Presence of parvovirus B19 DNA in chronic urticaric and healthy human skin. J Clin Virol 25:217–221. doi:10.1016/S1386-6532(02)00012-4

    Article  PubMed  CAS  Google Scholar 

  38. Willemze R, Jaffe ES, Burg G et al (2005) WHO-EORTC classification for cutaneous lymphomas. Blood 105:3768–3785. doi:10.1182/blood-2004-09-3502

    Article  PubMed  CAS  Google Scholar 

  39. Yazici AC, Aslan G, Baz K et al (2006) A high prevalence of parvovirus B19 DNA in patients with psoriasis. Arch Dermatol Res 298:231–235. doi:10.1007/s00403-006-0678-9

    Article  PubMed  CAS  Google Scholar 

Download references

This study was supported in part by a grant from the Regione Piemonte-Ricerca Sanitaria Finalizzata, 2005 A288.

Conflict of interest statement

The authors state no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maria Teresa Fierro.

Additional information

F. Sidoti and M. T. Fierro contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sidoti, F., Fierro, M.T., Costa, C. et al. Prevalence and significance of human parvovirus variants in skin from primary cutaneous T cell lymphomas, inflammatory dermatoses and healthy subjects. Arch Dermatol Res 301, 647–652 (2009). https://doi.org/10.1007/s00403-009-0954-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-009-0954-6

Keywords